REPORT: Understanding The Giant Cell Arteritis Market Landscape

Immunology

2023 Q3

Markets: Australia

An essential strategic resource for any organisation operating within this space. This report delivers a multi-dimensional view of the GCA landscape by integrating physician perceptions with real-world patient record data, capturing the complete clinical journey. It illuminates the path from a patient's first symptoms and their initial consultations with primary care, through the complex referral and diagnostic process, to the treatment decisions made by key specialists. By providing a clear understanding of clinician caseloads, patient profiles, and the challenges inherent in diagnosis, these insights will equip your team with the foundational knowledge to effectively engage with the medical community and understand the market's core dynamics.

Delve into physician satisfaction with current standards of care, identifying the pivotal factors that drive prescribing decisions, and gain a forward-looking perspective by assessing clinician awareness, familiarity, and prescribing intent for emerging pipeline therapies. This foresight is indispensable for anticipating shifts in the treatment paradigm, informing pre-launch activities, and sharpening your competitive strategy in a market poised for innovation.

  • Map the patient referral journey from primary care to specialist diagnosis to focus resources where they can most effectively shorten diagnosis timelines
  • Decode the drivers and satisfaction levels influencing treatment selection to build a value proposition that resonates with the clinical priorities of prescribers
  • Gauge the impact of barriers such as reimbursement restrictions and diagnostic challenges, to arm your teams with the evidence to support your brand's value story
  • Assess HCP awareness & prescribing intent for emerging therapies to aid with competitive positioning and to refine your product's launch strategy
  • Profile the GCA patient and prescriber base to ensure your commercial and medical activities are precisely targeted for maximum impact

  • Insights from a globally consistent data source
  • Physician-stated and real-world patient findings blended for a holistic view
  • Curated by Ipsos' dedicated immunology experts
Example column chart highlighting main challenges physicians face when diagnosing patients with GCA

Sample excerpt from report

  • 30 slides
  • Data collection timeframe: 2023 Q3
  • Data source: Ipsos GCA Therapy Monitor
  • Respondent type: HCPs, patient record forms
  • Regions shown: Australia
  • Consistent global data, large-scale datasets
Speak to the team